nodes	percent_of_prediction	percent_of_DWPC	metapath
Ephedrine—Urinary retention—Niacin—atherosclerosis	0.00832	0.0157	CcSEcCtD
Ephedrine—Arrhythmia—Rosuvastatin—atherosclerosis	0.00743	0.014	CcSEcCtD
Ephedrine—Angina pectoris—Niacin—atherosclerosis	0.00737	0.0139	CcSEcCtD
Ephedrine—Angina pectoris—Pravastatin—atherosclerosis	0.00725	0.0137	CcSEcCtD
Ephedrine—Dysuria—Pravastatin—atherosclerosis	0.00696	0.0131	CcSEcCtD
Ephedrine—Sweating—Niacin—atherosclerosis	0.00646	0.0122	CcSEcCtD
Ephedrine—Confusional state—Rosuvastatin—atherosclerosis	0.00596	0.0112	CcSEcCtD
Ephedrine—Muscle spasms—Lovastatin—atherosclerosis	0.0059	0.0111	CcSEcCtD
Ephedrine—Muscle spasms—Ezetimibe—atherosclerosis	0.00578	0.0109	CcSEcCtD
Ephedrine—Tremor—Lovastatin—atherosclerosis	0.00575	0.0109	CcSEcCtD
Ephedrine—Muscle spasms—Simvastatin—atherosclerosis	0.00552	0.0104	CcSEcCtD
Ephedrine—Vertigo—Lovastatin—atherosclerosis	0.00551	0.0104	CcSEcCtD
Ephedrine—Arrhythmia—Niacin—atherosclerosis	0.00541	0.0102	CcSEcCtD
Ephedrine—Tremor—Simvastatin—atherosclerosis	0.00538	0.0102	CcSEcCtD
Ephedrine—Insomnia—Rosuvastatin—atherosclerosis	0.00534	0.0101	CcSEcCtD
Ephedrine—Arrhythmia—Pravastatin—atherosclerosis	0.00532	0.0101	CcSEcCtD
Ephedrine—Palpitations—Ezetimibe—atherosclerosis	0.00532	0.01	CcSEcCtD
Ephedrine—Chest pain—Lovastatin—atherosclerosis	0.00522	0.00986	CcSEcCtD
Ephedrine—Anxiety—Lovastatin—atherosclerosis	0.0052	0.00983	CcSEcCtD
Ephedrine—Dyspepsia—Rosuvastatin—atherosclerosis	0.0052	0.00982	CcSEcCtD
Ephedrine—Hypertension—Ezetimibe—atherosclerosis	0.00519	0.00981	CcSEcCtD
Ephedrine—Tension—Niacin—atherosclerosis	0.00517	0.00976	CcSEcCtD
Ephedrine—Vertigo—Simvastatin—atherosclerosis	0.00516	0.00973	CcSEcCtD
Ephedrine—Chest pain—Ezetimibe—atherosclerosis	0.00512	0.00967	CcSEcCtD
Ephedrine—Nervousness—Niacin—atherosclerosis	0.00512	0.00966	CcSEcCtD
Ephedrine—Tension—Pravastatin—atherosclerosis	0.00509	0.00961	CcSEcCtD
Ephedrine—Muscle spasms—Niacin—atherosclerosis	0.00507	0.00956	CcSEcCtD
Ephedrine—Pain—Rosuvastatin—atherosclerosis	0.00505	0.00954	CcSEcCtD
Ephedrine—Confusional state—Lovastatin—atherosclerosis	0.00505	0.00953	CcSEcCtD
Ephedrine—Nervousness—Pravastatin—atherosclerosis	0.00504	0.00951	CcSEcCtD
Ephedrine—Muscle spasms—Pravastatin—atherosclerosis	0.00499	0.00942	CcSEcCtD
Ephedrine—Confusional state—Ezetimibe—atherosclerosis	0.00495	0.00935	CcSEcCtD
Ephedrine—Chest pain—Simvastatin—atherosclerosis	0.00489	0.00922	CcSEcCtD
Ephedrine—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00487	0.00919	CcSEcCtD
Ephedrine—Anxiety—Simvastatin—atherosclerosis	0.00487	0.00919	CcSEcCtD
Ephedrine—Tremor—Pravastatin—atherosclerosis	0.00486	0.00918	CcSEcCtD
Ephedrine—Anorexia—Lovastatin—atherosclerosis	0.00477	0.00901	CcSEcCtD
Ephedrine—Vertigo—Niacin—atherosclerosis	0.00473	0.00894	CcSEcCtD
Ephedrine—Confusional state—Simvastatin—atherosclerosis	0.00472	0.00892	CcSEcCtD
Ephedrine—Vertigo—Pravastatin—atherosclerosis	0.00466	0.0088	CcSEcCtD
Ephedrine—Palpitations—Niacin—atherosclerosis	0.00466	0.00879	CcSEcCtD
Ephedrine—Insomnia—Lovastatin—atherosclerosis	0.00453	0.00855	CcSEcCtD
Ephedrine—Hypertension—Pravastatin—atherosclerosis	0.00448	0.00846	CcSEcCtD
Ephedrine—Anorexia—Simvastatin—atherosclerosis	0.00446	0.00843	CcSEcCtD
Ephedrine—Dyspnoea—Lovastatin—atherosclerosis	0.00446	0.00843	CcSEcCtD
Ephedrine—Insomnia—Ezetimibe—atherosclerosis	0.00444	0.00839	CcSEcCtD
Ephedrine—Chest pain—Pravastatin—atherosclerosis	0.00442	0.00834	CcSEcCtD
Ephedrine—Dyspepsia—Lovastatin—atherosclerosis	0.00441	0.00832	CcSEcCtD
Ephedrine—Anxiety—Pravastatin—atherosclerosis	0.0044	0.00831	CcSEcCtD
Ephedrine—Dyspnoea—Ezetimibe—atherosclerosis	0.00438	0.00827	CcSEcCtD
Ephedrine—Decreased appetite—Lovastatin—atherosclerosis	0.00435	0.00822	CcSEcCtD
Ephedrine—Dyspepsia—Ezetimibe—atherosclerosis	0.00432	0.00816	CcSEcCtD
Ephedrine—Pain—Lovastatin—atherosclerosis	0.00428	0.00808	CcSEcCtD
Ephedrine—Confusional state—Pravastatin—atherosclerosis	0.00427	0.00806	CcSEcCtD
Ephedrine—Decreased appetite—Ezetimibe—atherosclerosis	0.00427	0.00806	CcSEcCtD
Ephedrine—Asthenia—Rosuvastatin—atherosclerosis	0.00424	0.008	CcSEcCtD
Ephedrine—Insomnia—Simvastatin—atherosclerosis	0.00424	0.008	CcSEcCtD
Ephedrine—Pain—Ezetimibe—atherosclerosis	0.0042	0.00793	CcSEcCtD
Ephedrine—Tachycardia—Niacin—atherosclerosis	0.0042	0.00792	CcSEcCtD
Ephedrine—Dyspnoea—Simvastatin—atherosclerosis	0.00418	0.00788	CcSEcCtD
Ephedrine—Hyperhidrosis—Niacin—atherosclerosis	0.00416	0.00785	CcSEcCtD
Ephedrine—Feeling abnormal—Lovastatin—atherosclerosis	0.00413	0.00779	CcSEcCtD
Ephedrine—Dyspepsia—Simvastatin—atherosclerosis	0.00412	0.00778	CcSEcCtD
Ephedrine—Anorexia—Niacin—atherosclerosis	0.0041	0.00774	CcSEcCtD
Ephedrine—Hyperhidrosis—Pravastatin—atherosclerosis	0.00409	0.00773	CcSEcCtD
Ephedrine—Decreased appetite—Simvastatin—atherosclerosis	0.00407	0.00769	CcSEcCtD
Ephedrine—Feeling abnormal—Ezetimibe—atherosclerosis	0.00405	0.00764	CcSEcCtD
Ephedrine—Anorexia—Pravastatin—atherosclerosis	0.00404	0.00762	CcSEcCtD
Ephedrine—Pain—Simvastatin—atherosclerosis	0.004	0.00756	CcSEcCtD
Ephedrine—Body temperature increased—Lovastatin—atherosclerosis	0.00396	0.00747	CcSEcCtD
Ephedrine—Dizziness—Rosuvastatin—atherosclerosis	0.00391	0.00738	CcSEcCtD
Ephedrine—Insomnia—Niacin—atherosclerosis	0.00389	0.00734	CcSEcCtD
Ephedrine—Body temperature increased—Ezetimibe—atherosclerosis	0.00388	0.00733	CcSEcCtD
Ephedrine—Feeling abnormal—Simvastatin—atherosclerosis	0.00386	0.00729	CcSEcCtD
Ephedrine—Dyspnoea—Niacin—atherosclerosis	0.00383	0.00724	CcSEcCtD
Ephedrine—Insomnia—Pravastatin—atherosclerosis	0.00383	0.00723	CcSEcCtD
Ephedrine—Dyspepsia—Niacin—atherosclerosis	0.00379	0.00715	CcSEcCtD
Ephedrine—Dyspnoea—Pravastatin—atherosclerosis	0.00377	0.00713	CcSEcCtD
Ephedrine—Decreased appetite—Niacin—atherosclerosis	0.00374	0.00706	CcSEcCtD
Ephedrine—Dyspepsia—Pravastatin—atherosclerosis	0.00373	0.00704	CcSEcCtD
Ephedrine—Rash—Rosuvastatin—atherosclerosis	0.00372	0.00703	CcSEcCtD
Ephedrine—Dermatitis—Rosuvastatin—atherosclerosis	0.00372	0.00703	CcSEcCtD
Ephedrine—Body temperature increased—Simvastatin—atherosclerosis	0.0037	0.00699	CcSEcCtD
Ephedrine—Headache—Rosuvastatin—atherosclerosis	0.0037	0.00699	CcSEcCtD
Ephedrine—Decreased appetite—Pravastatin—atherosclerosis	0.00368	0.00695	CcSEcCtD
Ephedrine—Pain—Niacin—atherosclerosis	0.00368	0.00694	CcSEcCtD
Ephedrine—Pain—Pravastatin—atherosclerosis	0.00362	0.00684	CcSEcCtD
Ephedrine—Asthenia—Lovastatin—atherosclerosis	0.00359	0.00678	CcSEcCtD
Ephedrine—Asthenia—Ezetimibe—atherosclerosis	0.00352	0.00665	CcSEcCtD
Ephedrine—Nausea—Rosuvastatin—atherosclerosis	0.00351	0.00663	CcSEcCtD
Ephedrine—Feeling abnormal—Pravastatin—atherosclerosis	0.00349	0.00659	CcSEcCtD
Ephedrine—Body temperature increased—Niacin—atherosclerosis	0.0034	0.00642	CcSEcCtD
Ephedrine—Asthenia—Simvastatin—atherosclerosis	0.00336	0.00634	CcSEcCtD
Ephedrine—Body temperature increased—Pravastatin—atherosclerosis	0.00335	0.00632	CcSEcCtD
Ephedrine—Dizziness—Lovastatin—atherosclerosis	0.00331	0.00625	CcSEcCtD
Ephedrine—Dizziness—Ezetimibe—atherosclerosis	0.00325	0.00613	CcSEcCtD
Ephedrine—Vomiting—Lovastatin—atherosclerosis	0.00318	0.00601	CcSEcCtD
Ephedrine—Rash—Lovastatin—atherosclerosis	0.00316	0.00596	CcSEcCtD
Ephedrine—Dermatitis—Lovastatin—atherosclerosis	0.00315	0.00595	CcSEcCtD
Ephedrine—Headache—Lovastatin—atherosclerosis	0.00314	0.00592	CcSEcCtD
Ephedrine—Vomiting—Ezetimibe—atherosclerosis	0.00312	0.0059	CcSEcCtD
Ephedrine—Dizziness—Simvastatin—atherosclerosis	0.0031	0.00585	CcSEcCtD
Ephedrine—Rash—Ezetimibe—atherosclerosis	0.0031	0.00585	CcSEcCtD
Ephedrine—Dermatitis—Ezetimibe—atherosclerosis	0.00309	0.00584	CcSEcCtD
Ephedrine—Asthenia—Niacin—atherosclerosis	0.00309	0.00583	CcSEcCtD
Ephedrine—Headache—Ezetimibe—atherosclerosis	0.00308	0.00581	CcSEcCtD
Ephedrine—Asthenia—Pravastatin—atherosclerosis	0.00304	0.00574	CcSEcCtD
Ephedrine—Vomiting—Simvastatin—atherosclerosis	0.00298	0.00562	CcSEcCtD
Ephedrine—Nausea—Lovastatin—atherosclerosis	0.00297	0.00562	CcSEcCtD
Ephedrine—Rash—Simvastatin—atherosclerosis	0.00295	0.00558	CcSEcCtD
Ephedrine—Dermatitis—Simvastatin—atherosclerosis	0.00295	0.00557	CcSEcCtD
Ephedrine—Headache—Simvastatin—atherosclerosis	0.00293	0.00554	CcSEcCtD
Ephedrine—Nausea—Ezetimibe—atherosclerosis	0.00292	0.00551	CcSEcCtD
Ephedrine—Dizziness—Niacin—atherosclerosis	0.00284	0.00537	CcSEcCtD
Ephedrine—Dizziness—Pravastatin—atherosclerosis	0.0028	0.00529	CcSEcCtD
Ephedrine—Nausea—Simvastatin—atherosclerosis	0.00278	0.00525	CcSEcCtD
Ephedrine—Vomiting—Niacin—atherosclerosis	0.00273	0.00516	CcSEcCtD
Ephedrine—Rash—Niacin—atherosclerosis	0.00271	0.00512	CcSEcCtD
Ephedrine—Dermatitis—Niacin—atherosclerosis	0.00271	0.00511	CcSEcCtD
Ephedrine—Headache—Niacin—atherosclerosis	0.00269	0.00509	CcSEcCtD
Ephedrine—Vomiting—Pravastatin—atherosclerosis	0.00269	0.00508	CcSEcCtD
Ephedrine—Rash—Pravastatin—atherosclerosis	0.00267	0.00504	CcSEcCtD
Ephedrine—Dermatitis—Pravastatin—atherosclerosis	0.00267	0.00504	CcSEcCtD
Ephedrine—Headache—Pravastatin—atherosclerosis	0.00265	0.00501	CcSEcCtD
Ephedrine—Nausea—Niacin—atherosclerosis	0.00255	0.00482	CcSEcCtD
Ephedrine—Nausea—Pravastatin—atherosclerosis	0.00251	0.00475	CcSEcCtD
Ephedrine—ACHE—Metabolism—APOC3—atherosclerosis	0.000245	0.00052	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—LEP—atherosclerosis	0.000244	0.00052	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—LDLR—atherosclerosis	0.000243	0.000517	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—GHRL—atherosclerosis	0.000243	0.000516	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—AGT—atherosclerosis	0.00024	0.000511	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—CCL2—atherosclerosis	0.000239	0.000509	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCL4—atherosclerosis	0.000238	0.000506	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CETP—atherosclerosis	0.000238	0.000505	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—KNG1—atherosclerosis	0.000235	0.000499	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	0.000233	0.000496	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—AGTR1—atherosclerosis	0.000233	0.000496	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—F2—atherosclerosis	0.000231	0.00049	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CCL3—atherosclerosis	0.000228	0.000484	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.000228	0.000484	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—SCARB1—atherosclerosis	0.000228	0.000484	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CCR2—atherosclerosis	0.000227	0.000482	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—EDNRA—atherosclerosis	0.000227	0.000482	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—MMP1—atherosclerosis	0.000225	0.000479	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—APOA2—atherosclerosis	0.000223	0.000473	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—AGT—atherosclerosis	0.000223	0.000473	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—F2—atherosclerosis	0.000222	0.000472	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.000222	0.000471	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—GHRL—atherosclerosis	0.000221	0.00047	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—NAMPT—atherosclerosis	0.000221	0.00047	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.00022	0.000467	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—LIPC—atherosclerosis	0.00022	0.000467	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—APOC3—atherosclerosis	0.000218	0.000464	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—LEP—atherosclerosis	0.000218	0.000464	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—LDLR—atherosclerosis	0.000217	0.000461	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—HMGCR—atherosclerosis	0.000215	0.000457	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—APOA4—atherosclerosis	0.000214	0.000455	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—atherosclerosis	0.000213	0.000453	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—KNG1—atherosclerosis	0.000213	0.000453	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—UTS2—atherosclerosis	0.000212	0.000451	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CETP—atherosclerosis	0.000212	0.000451	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—AGTR1—atherosclerosis	0.000212	0.00045	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—INS—atherosclerosis	0.000209	0.000444	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—ALB—atherosclerosis	0.000208	0.000443	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CCR2—atherosclerosis	0.000206	0.000438	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—EDNRA—atherosclerosis	0.000206	0.000438	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—F2—atherosclerosis	0.000206	0.000437	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—CCL2—atherosclerosis	0.000205	0.000437	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atherosclerosis	0.000205	0.000437	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CX3CR1—atherosclerosis	0.000204	0.000433	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CASR—atherosclerosis	0.000204	0.000433	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—SCARB1—atherosclerosis	0.000203	0.000432	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—IGF1—atherosclerosis	0.000202	0.000429	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—GHRL—atherosclerosis	0.000201	0.000427	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CX3CL1—atherosclerosis	0.0002	0.000424	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—CCL2—atherosclerosis	0.000198	0.000421	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—EDN1—atherosclerosis	0.000198	0.00042	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.000198	0.00042	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCL4—atherosclerosis	0.000197	0.000419	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—CCL5—atherosclerosis	0.000196	0.000417	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—MMP2—atherosclerosis	0.000195	0.000416	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—KNG1—atherosclerosis	0.000194	0.000413	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.000194	0.000412	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—AGTR1—atherosclerosis	0.000193	0.00041	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—HMGCR—atherosclerosis	0.000192	0.000408	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ABCA1—atherosclerosis	0.000192	0.000407	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CNR2—atherosclerosis	0.000189	0.000402	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—CXCL8—atherosclerosis	0.000189	0.000402	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—MMP3—atherosclerosis	0.000189	0.000401	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PRKCG—atherosclerosis	0.000187	0.000397	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—INS—atherosclerosis	0.000186	0.000396	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—APOA2—atherosclerosis	0.000184	0.000391	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—CCL2—atherosclerosis	0.000183	0.00039	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—IGF1—atherosclerosis	0.00018	0.000383	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—EDN1—atherosclerosis	0.00018	0.000382	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CCL5—atherosclerosis	0.000178	0.000379	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—KNG1—atherosclerosis	0.000176	0.000375	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—UTS2—atherosclerosis	0.000176	0.000373	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—AGTR1—atherosclerosis	0.000175	0.000373	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—MMP2—atherosclerosis	0.000174	0.000371	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.000173	0.000368	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ABCA1—atherosclerosis	0.000171	0.000363	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PRKCG—atherosclerosis	0.000169	0.00036	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—VWF—atherosclerosis	0.000169	0.000359	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CX3CR1—atherosclerosis	0.000168	0.000358	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CASR—atherosclerosis	0.000168	0.000358	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—APOC3—atherosclerosis	0.000168	0.000356	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—LDLR—atherosclerosis	0.000167	0.000354	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CX3CL1—atherosclerosis	0.000165	0.000351	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—HMOX1—atherosclerosis	0.000164	0.000349	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—AGT—atherosclerosis	0.000164	0.000349	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—EDN1—atherosclerosis	0.000164	0.000348	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCL3—atherosclerosis	0.000163	0.000346	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—CXCL8—atherosclerosis	0.000162	0.000345	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CCL5—atherosclerosis	0.000162	0.000345	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—APOB—atherosclerosis	0.000157	0.000335	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CNR2—atherosclerosis	0.000157	0.000333	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—CXCL8—atherosclerosis	0.000156	0.000333	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—MMP3—atherosclerosis	0.000156	0.000332	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NCF1—atherosclerosis	0.000156	0.000331	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atherosclerosis	0.000156	0.000331	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PRKCG—atherosclerosis	0.000154	0.000328	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GSTM1—atherosclerosis	0.000153	0.000326	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—F2—atherosclerosis	0.000152	0.000322	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—LPL—atherosclerosis	0.00015	0.00032	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—AGT—atherosclerosis	0.000149	0.000317	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—EDN1—atherosclerosis	0.000149	0.000316	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CCL5—atherosclerosis	0.000147	0.000313	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCR2—atherosclerosis	0.000147	0.000313	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—EDNRA—atherosclerosis	0.000147	0.000313	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GPX1—atherosclerosis	0.000147	0.000312	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—HMOX1—atherosclerosis	0.000147	0.000312	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CYBA—atherosclerosis	0.000147	0.000312	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000145	0.000309	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—CXCL8—atherosclerosis	0.000145	0.000308	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—GHRL—atherosclerosis	0.000143	0.000305	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PLAT—atherosclerosis	0.000143	0.000305	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PARP1—atherosclerosis	0.000143	0.000305	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CD36—atherosclerosis	0.000143	0.000304	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—APOB—atherosclerosis	0.00014	0.000299	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PRKCG—atherosclerosis	0.00014	0.000298	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—VWF—atherosclerosis	0.00014	0.000297	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—APOC3—atherosclerosis	0.000139	0.000295	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—LDLR—atherosclerosis	0.000138	0.000293	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—F2—atherosclerosis	0.000138	0.000293	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GSTM1—atherosclerosis	0.000137	0.00029	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—AGT—atherosclerosis	0.000136	0.000289	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—MTHFR—atherosclerosis	0.000135	0.000288	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCL3—atherosclerosis	0.000135	0.000286	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—LPL—atherosclerosis	0.000134	0.000285	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PPARA—atherosclerosis	0.000133	0.000282	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CG—atherosclerosis	0.000132	0.00028	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GPX1—atherosclerosis	0.000131	0.000278	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NCF1—atherosclerosis	0.000129	0.000274	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—AGT—atherosclerosis	0.000129	0.000273	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CD36—atherosclerosis	0.000127	0.000271	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—APOE—atherosclerosis	0.000126	0.000268	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—KNG1—atherosclerosis	0.000126	0.000268	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—F2—atherosclerosis	0.000125	0.000267	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AGTR1—atherosclerosis	0.000125	0.000266	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CAV1—atherosclerosis	0.000125	0.000265	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—APOA1—atherosclerosis	0.000125	0.000265	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—AGT—atherosclerosis	0.000123	0.000262	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CCL2—atherosclerosis	0.000123	0.000261	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PLG—atherosclerosis	0.000122	0.000259	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCR2—atherosclerosis	0.000122	0.000259	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—EDNRA—atherosclerosis	0.000122	0.000259	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CYBA—atherosclerosis	0.000121	0.000258	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—MTHFR—atherosclerosis	0.000121	0.000257	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CG—atherosclerosis	0.00012	0.000255	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PLAT—atherosclerosis	0.000119	0.000252	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PARP1—atherosclerosis	0.000119	0.000252	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GHRL—atherosclerosis	0.000119	0.000252	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PPARA—atherosclerosis	0.000118	0.000252	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SOCS3—atherosclerosis	0.000115	0.000246	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—AGT—atherosclerosis	0.000115	0.000244	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—F2—atherosclerosis	0.000114	0.000242	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CG—atherosclerosis	0.000114	0.000242	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—APOE—atherosclerosis	0.000112	0.000239	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MMP3—atherosclerosis	0.000112	0.000237	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CAV1—atherosclerosis	0.000111	0.000237	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—APOA1—atherosclerosis	0.000111	0.000236	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IGF2—atherosclerosis	0.000111	0.000236	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PPARG—atherosclerosis	0.00011	0.000233	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CG—atherosclerosis	0.000109	0.000232	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—APOB—atherosclerosis	0.000108	0.000229	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—INS—atherosclerosis	0.000108	0.000229	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—CXCL8—atherosclerosis	0.000107	0.000227	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—EDN1—atherosclerosis	0.000106	0.000226	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCL5—atherosclerosis	0.000105	0.000224	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—KNG1—atherosclerosis	0.000104	0.000221	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AGTR1—atherosclerosis	0.000104	0.00022	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—LPL—atherosclerosis	0.000103	0.000219	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CCL2—atherosclerosis	0.000102	0.000216	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CG—atherosclerosis	0.000101	0.000216	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PLG—atherosclerosis	0.000101	0.000214	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PRKCG—atherosclerosis	0.0001	0.000213	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ALB—atherosclerosis	9.87e-05	0.00021	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PPARG—atherosclerosis	9.79e-05	0.000208	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SPP1—atherosclerosis	9.75e-05	0.000207	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CXCL8—atherosclerosis	9.71e-05	0.000206	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—INS—atherosclerosis	9.6e-05	0.000204	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SOCS3—atherosclerosis	9.55e-05	0.000203	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—NOS3—atherosclerosis	9.44e-05	0.000201	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MMP3—atherosclerosis	9.23e-05	0.000196	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IGF2—atherosclerosis	9.19e-05	0.000195	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PDGFB—atherosclerosis	9.02e-05	0.000192	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—APOB—atherosclerosis	8.92e-05	0.00019	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CXCL8—atherosclerosis	8.84e-05	0.000188	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AGT—atherosclerosis	8.81e-05	0.000187	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ALB—atherosclerosis	8.8e-05	0.000187	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—EDN1—atherosclerosis	8.78e-05	0.000187	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCL5—atherosclerosis	8.71e-05	0.000185	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PTGS2—atherosclerosis	8.63e-05	0.000184	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—APOE—atherosclerosis	8.63e-05	0.000183	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—LEP—atherosclerosis	8.63e-05	0.000183	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CAV1—atherosclerosis	8.55e-05	0.000182	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—APOA1—atherosclerosis	8.53e-05	0.000181	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—LPL—atherosclerosis	8.51e-05	0.000181	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—NOS3—atherosclerosis	8.42e-05	0.000179	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PRKCG—atherosclerosis	8.28e-05	0.000176	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ESR1—atherosclerosis	8.24e-05	0.000175	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—F2—atherosclerosis	8.14e-05	0.000173	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SPP1—atherosclerosis	8.06e-05	0.000171	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CXCL8—atherosclerosis	8.03e-05	0.000171	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CG—atherosclerosis	7.79e-05	0.000166	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PTGS2—atherosclerosis	7.7e-05	0.000164	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PDGFB—atherosclerosis	7.46e-05	0.000159	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—MAPK3—atherosclerosis	7.46e-05	0.000159	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—INS—atherosclerosis	7.37e-05	0.000157	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AGT—atherosclerosis	7.28e-05	0.000155	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCL2—atherosclerosis	7.25e-05	0.000154	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—LEP—atherosclerosis	7.14e-05	0.000152	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—APOE—atherosclerosis	7.14e-05	0.000152	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IGF1—atherosclerosis	7.13e-05	0.000152	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CAV1—atherosclerosis	7.07e-05	0.00015	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—APOA1—atherosclerosis	7.06e-05	0.00015	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ESR1—atherosclerosis	6.81e-05	0.000145	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SERPINE1—atherosclerosis	6.77e-05	0.000144	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—F2—atherosclerosis	6.73e-05	0.000143	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NOS3—atherosclerosis	6.46e-05	0.000137	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CG—atherosclerosis	6.44e-05	0.000137	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—MAPK3—atherosclerosis	6.17e-05	0.000131	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—INS—atherosclerosis	6.1e-05	0.00013	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCL2—atherosclerosis	6e-05	0.000128	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IGF1—atherosclerosis	5.9e-05	0.000125	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CXCL8—atherosclerosis	5.73e-05	0.000122	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	5.6e-05	0.000119	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—AKT1—atherosclerosis	5.54e-05	0.000118	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—IL6—atherosclerosis	5.45e-05	0.000116	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	5.35e-05	0.000114	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MMP9—atherosclerosis	5.19e-05	0.00011	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NFKB1—atherosclerosis	5.13e-05	0.000109	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MAPK8—atherosclerosis	5.04e-05	0.000107	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—AKT1—atherosclerosis	5.03e-05	0.000107	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	4.74e-05	0.000101	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—VEGFA—atherosclerosis	4.66e-05	9.9e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—STAT3—atherosclerosis	4.61e-05	9.8e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	4.58e-05	9.74e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	4.51e-05	9.59e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MAPK3—atherosclerosis	4.41e-05	9.37e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—AKT1—atherosclerosis	4.34e-05	9.22e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	4.29e-05	9.12e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TGFB1—atherosclerosis	4.27e-05	9.09e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	4.24e-05	9.02e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	4.17e-05	8.87e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	4.16e-05	8.85e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—AKT1—atherosclerosis	3.87e-05	8.23e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	3.85e-05	8.19e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	3.81e-05	8.11e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	3.64e-05	7.75e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	3.54e-05	7.52e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL6—atherosclerosis	3.22e-05	6.85e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AKT1—atherosclerosis	2.97e-05	6.32e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL6—atherosclerosis	2.66e-05	5.66e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	2.46e-05	5.23e-05	CbGpPWpGaD
